Table 4.
Patient No. |
Sex/Age (yr) | Global Sclerosis |
Segmental Sclerosis |
Glomerular Hyaline | Interstitial Fibrosis | Tubular Atrophy |
Arterio- Pathy |
Podocyte GL3 Deposits | Tubular GL3 Deposits |
Glomerular Endothelial Cell GL3 Deposits |
---|---|---|---|---|---|---|---|---|---|---|
1 | M/17 | + | + | − | + | NA | + | + | + | + |
2 | M/10 | − | − | − | − | − | − | + | + | + |
3 | M/41 | − | − | − | + | NA | + | + | + | + |
4 | M/26 | − | − | − | − | − | − | + | + | + |
5 | M/44 | − | + | + | + | + | + | + | + | + |
6 | M/39 | + | + | + | + | + | − | + | + | + |
7 | M/29 | − | + | − | − | − | − | + | + | + |
8 | F/50 | + | + | − | + | + | + | + | + | + |
9 | F/55 | + | + | + | + | + | + | + | + | + |
10 | F/49 | − | − | − | − | + | − | + | + | + |
11 | F/46 | − | − | − | − | − | − | + | + | + |
12 | F/30 | − | − | − | − | − | − | + | + | + |
13 | F/35 | − | − | − | − | − | − | + | + | + |
14 | F/63 | − | − | − | − | NA | − | + | + | − |
15 | F/35 | + | + | − | − | − | + | + | + | + |
16 | F/61 | − | − | − | + | NA | + | + | + | + |
17 * | M/43 | − | + | − | + | + | + | + | + | + |
18 * | M/32 | − | − | − | − | − | − | + | + | + |
19 * | M/58 | − | + | − | + | + | − | + | + | + |
20 * | M/37 | + | + | − | + | + | − | + | + | + |
21 * | F/57 | − | + | + | − | − | − | + | + | + |
* Previously enzyme replacement therapy-treated patients; Plus (+) sign represents the presence and minus (−) sign represent the absence; M = male, F = female; NA = not applicable; GL3 = globotrioasylceramide.